STE vs TRAK · P/E 25, rev $5.46B vs P/E 25, $167.9M cap
STERIS plc (STE) versus ReposiTrak (TRAK) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
ReposiTrak (TRAK) is a software - application company listed on NYSE.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
TRAK does not have a complete income-statement cache yet.
STE currently screens at market cap $19.43B and trailing P/E 25.1. TRAK currently screens at market cap $167.9M and trailing P/E 25.0.
Not investment advice. Open the STE and TRAK stock pages for the full models.
Not investment advice.